Trial intelligence / Profile preview

Opioid-sparing analgesia versus morphine after surgery in obese patients at risk of postoperative respiratory obstruction

ACTRN12607000208404Phase 4Not yet recruiting

Sponsor
Royal Melbourne Hospital
Start
Jun 2007
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of morphine, parecoxib, ketamine and tramadol in postoperative pain (2 arms), sponsored by Royal Melbourne Hospital. Primary endpoint: Reduced number of respiratory obstructions or desaturations. Planned start Jun 2007; status: not yet recruiting.

02

Drugs

morphineparecoxibketaminetramadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12607000208404.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12607000208404.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call